SEI Investments Portfolio holdings
AUM
$86.3B
1-Year Return
22.26%
This Quarter Return
-1.7%
1 Year Return
+22.26%
3 Year Return
+83.74%
5 Year Return
+138.48%
10 Year Return
+342.87%
AUM
$77.7B
AUM Growth
-$171M
(-0.22%)
Cap. Flow
+$2.62B
Cap. Flow
% of AUM
3.37%
Top 10 Holdings %
Top 10 Hldgs %
17.15%
Holding
2,883
New
162
Increased
1,461
Reduced
942
Closed
126
Top Buys
| 1 |
Visa
V
|
+$188M |
| 2 |
Eli Lilly
LLY
|
+$121M |
| 3 |
Broadcom
AVGO
|
+$120M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$114M |
| 5 |
Baker Hughes
BKR
|
+$98M |
Top Sells
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$123M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$79.8M |
| 3 |
Automatic Data Processing
ADP
|
+$78.2M |
| 4 |
Eaton
ETN
|
+$74M |
| 5 |
Quanta Services
PWR
|
+$73M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Financials | 11.1% |
| 3 | Healthcare | 9.08% |
| 4 | Consumer Discretionary | 8.63% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Sutro Biopharma
STRO
$82.3M
| $36.7K | ﹤0.01% |
56,347
| – | – |
|
2627
ProKidney
PROK
$298M
| $36K | ﹤0.01% |
41,042
-20
| -0% | -$18 |
|
2628
ImmunityBio
IBRX
$2.43B
| $35.5K | ﹤0.01% |
+11,809
| New | +$35.5K |
|
2629
Black Diamond Therapeutics
BDTX
$185M
| $35.3K | ﹤0.01% |
22,802
| – | – |
|
2630
NET Power
NPWR
$167M
| $33.8K | ﹤0.01% |
+12,854
| New | +$33.8K |
|
2631
3D Systems Corporation
DDD
$269M
| $33.2K | ﹤0.01% |
15,680
+4,155
| +36% | +$8.81K |
|
|
RDNW
2632
RideNow Group, Inc. Class B Common Stock
RDNW
$148M
| $33.2K | ﹤0.01% |
11,785
| – | – |
|
2633
Cibus
CBUS
$74.1M
| $33.2K | ﹤0.01% |
17,744
| – | – |
|
2634
Fractyl Health
GUTS
$68.9M
| $33.1K | ﹤0.01% |
27,778
| – | – |
|
2635
Smart Sand
SND
$75.5M
| $32.7K | ﹤0.01% |
+12,610
| New | +$32.7K |
|
2636
Bit Digital
BTBT
$890M
| $32.6K | ﹤0.01% |
16,133
| – | – |
|
2637
ADC Therapeutics
ADCT
$373M
| $32.4K | ﹤0.01% |
22,989
| – | – |
|
2638
Vivid Seats
SEAT
$102M
| $32K | ﹤0.01% |
+541
| New | +$32K |
|
2639
Microvision
MVIS
$343M
| $31.5K | ﹤0.01% |
25,404
| – | – |
|
2640
Codexis
CDXS
$221M
| $31.5K | ﹤0.01% |
11,708
-850
| -7% | -$2.29K |
|
2641
Chegg
CHGG
$168M
| $31K | ﹤0.01% |
48,435
+38,083
| +368% | +$24.3K |
|
2642
Cerus
CERS
$247M
| $30.8K | ﹤0.01% |
22,140
| – | – |
|
2643
Vera Bradley
VRA
$64.2M
| $30.7K | ﹤0.01% |
13,628
| – | – |
|
2644
Lyell Immunopharma
LYEL
$253M
| $30.1K | ﹤0.01% |
2,795
| – | – |
|
|
SRTA
2645
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$329M
| $29.9K | ﹤0.01% |
10,945
| – | – |
|
2646
Sana Biotechnology
SANA
$767M
| $29.7K | ﹤0.01% |
17,668
| – | – |
|
|
QD
2647
Qudian
QD
$698M
| $28.9K | ﹤0.01% |
10,731
| – | – |
|
2648
Heron Therapeutics
HRTX
$199M
| $27.9K | ﹤0.01% |
12,685
| – | – |
|
2649
Amprius Technologies
AMPX
$978M
| $27.4K | ﹤0.01% |
10,229
| – | – |
|
2650
Innoviz Technologies
INVZ
$375M
| $27.2K | ﹤0.01% |
41,815
+23,075
| +123% | +$15K |
|